0001144204-15-047363.txt : 20150807 0001144204-15-047363.hdr.sgml : 20150807 20150807165436 ACCESSION NUMBER: 0001144204-15-047363 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150807 DATE AS OF CHANGE: 20150807 EFFECTIVENESS DATE: 20150807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LabStyle Innovations Corp. CENTRAL INDEX KEY: 0001533998 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 452973162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-245339 FILM NUMBER: 151038227 BUSINESS ADDRESS: STREET 1: HALAMISH 9 CITY: CAESAREA INDUSTRIAL PARK STATE: L3 ZIP: 38900 BUSINESS PHONE: (972)-(3)-6222929 MAIL ADDRESS: STREET 1: HALAMISH 9 CITY: CAESAREA INDUSTRIAL PARK STATE: L3 ZIP: 38900 D 1 primary_doc.xml X0707 D LIVE 0001533998 LabStyle Innovations Corp. HALAMISH 9 CAESAREA L3 ISRAEL 38900 +972-4-7706377 DELAWARE None None Corporation true 2011 Erez Raphael c/o LabStyle Innovations Corp. Halamish 9 Caesarea L3 ISRAEL 38900 Executive Officer Director Zvi Ben David c/o LabStyle Innovations Corp. Halamish 9 Caesarea L3 ISRAEL 38900 Executive Officer Malcolm Hoenlein c/o LabStyle Innovations Corp. Halamish 9 Caesarea L3 ISRAEL 38900 Director Dennis McGrath c/o LabStyle Innovations Corp. Halamish 9 Caesarea L3 ISRAEL 38900 Director Richard Stone c/o LabStyle Innovations Corp. Halamish 9 Caesarea L3 ISRAEL 38900 Director Rami Yehudiha c/o LabStyle Innovations Corp. Halamish 9 Caesarea L3 ISRAEL 38900 Director Hila Karah c/o LabStyle Innovations Corp. Halamish 9 Caesarea L3 ISRAEL 38900 Director Biotechnology $1 - $1,000,000 06b false 2015-07-23 false true true true false 1000 Maxim Group LLC 120708 Newport Coast Securities, Inc. 16944 405 LEXINGTON AVENUE NEW YORK NY NEW YORK 10174 CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA LA LOUISIANA NJ NEW JERSEY NY NEW YORK TX TEXAS WA WASHINGTON WI WISCONSIN false 2255391 789550 1465841 false 22 91181 0 The sales commissions only represent the total cash compensation. In addition to the cash compensation, the Company also issued 50,000 of its common shares and 850,044 warrants for its common shares to the two placement agents. 0 false LabStyle Innovations Corp. /s/ Zvi Ben David Zvi Ben David Chief Financial Officer, Treasurer and Secretary 2015-08-07